31287614|t|High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-beta.
31287614|a|Although the interaction of apoE isoforms with amyloid-beta (Abeta) peptides plays a critical role in the progression of Alzheimer's disease, how they interact with each other remains poorly understood. Here, we investigate the molecular mechanism of apoE-Abeta interactions by comparing the effects of the different domains of apoE on Abeta. The kinetics of aggregation of Abeta1-42 are delayed dramatically in the presence of substoichiometric, nanomolar concentrations of N-terminal fragment (NTF), C-terminal fragment (CTF) and full-length apoE both in lipid-free and in lipidated forms. However, interactions between apoE and Abeta as measured by intermolecular Forster resonance energy transfer (FRET) analysis were found to be minimal at t = 0 but to increase in a time-dependent manner. Thus, apoE must interact with one or more 'intermediates' rather than the monomers of Abeta. Kinetics of FRET between full-length apoE4 labelled with EDANS at position 62 or 139 or 210 or 247 or 276, and tetramethylrhodamine-labelled Abeta (TMR-Abeta), further support an involvement of all the three domains of apoE in the interactions. However, the above-mentioned residues do not appear to form a single pocket in the 3-dimensional structure of apoE. A competitive binding assay examining the effects of unlabelled fragments or full-length apoE on the FRET between EDANS-apoE and TMR-Abeta show that binding affinity of the full-length apoE to Abeta is much higher than that of the fragments. Furthermore, apoE4 is found to interact more strongly than apoE3. We hypothesize that high affinity of the apoE-Abeta interaction is attained due to multivalent binding mediated by multiple interactions between oligomeric Abeta and full-length apoE.
31287614	47	63	apolipoprotein E	Gene	348
31287614	85	97	amyloid-beta	Gene	351
31287614	127	131	apoE	Gene	348
31287614	146	158	amyloid-beta	Gene	351
31287614	160	165	Abeta	Gene	351
31287614	220	239	Alzheimer's disease	Disease	MESH:D000544
31287614	350	354	apoE	Gene	348
31287614	355	360	Abeta	Gene	351
31287614	427	431	apoE	Gene	348
31287614	435	440	Abeta	Gene	351
31287614	643	647	apoE	Gene	348
31287614	656	661	lipid	Chemical	MESH:D008055
31287614	721	725	apoE	Gene	348
31287614	730	735	Abeta	Gene	351
31287614	900	904	apoE	Gene	348
31287614	980	985	Abeta	Gene	351
31287614	1024	1029	apoE4	Gene	348
31287614	1044	1049	EDANS	Chemical	MESH:C063126
31287614	1098	1118	tetramethylrhodamine	Chemical	MESH:C005358
31287614	1128	1133	Abeta	Gene	351
31287614	1135	1138	TMR	Chemical	-
31287614	1139	1144	Abeta	Gene	351
31287614	1206	1210	apoE	Gene	348
31287614	1342	1347	apoE.	Gene	348
31287614	1437	1441	apoE	Gene	348
31287614	1462	1467	EDANS	CellLine	
31287614	1468	1472	apoE	Gene	348
31287614	1477	1480	TMR	Chemical	-
31287614	1481	1486	Abeta	Gene	351
31287614	1533	1537	apoE	Gene	348
31287614	1541	1546	Abeta	Gene	351
31287614	1603	1608	apoE4	Gene	348
31287614	1649	1654	apoE3	Gene	348
31287614	1697	1701	apoE	Gene	348
31287614	1702	1707	Abeta	Gene	351
31287614	1812	1817	Abeta	Gene	351
31287614	Association	MESH:C005358	351
31287614	Association	348	351
31287614	Association	MESH:D000544	351
31287614	Bind	MESH:C063126	348

